Developer docs
API playgroundTry for free, no card

Search company profiles

Bioeksen R&D Technologies

Full company profile

uuid000js53

Namestring
Bioeksen R&D Technologies
Websiteurl
bioeksen.com.tr
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Bioeksen R&D Technologies is a private, for-profit biotechnology firm headquartered in Istanbul, Turkey, founded in 2014. According to its firmographic profile, the company develops and offers molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing (NGS) services. This positions it within the clinical and research molecular diagnostics value chain, serving customers who require nucleic-acid-based pathogen detection, genetic testing, and sequencing-based analysis.

The company's product surface spans three interrelated layers: instrumentation (molecular diagnostic systems), consumables (real-time PCR test kits), and service revenue (NGS services). This combination suggests an integrated model where the firm both sells physical diagnostic products and performs sequencing work on behalf of clients, typical of small-cap molecular diagnostics boutiques that compete on assay design, turnaround time, and local-market reach. Founded in 2014 and headquartered in Istanbul, Bioeksen operates with a headcount of 11-50 employees, indicating a small, specialist team rather than a scaled commercial platform.

The input data does not disclose pricing models, customer segments, distribution channels, go-to-market strategy, or ownership details. The company's website was inaccessible at the time of capture (presenting only a loader/verification page), which prevented extraction of corporate history, investor information, certifications, or partnerships. Consequently, the business model — specifically how revenue is split between kit sales, instrument placement, and service fees, and whether customers are concentrated in Turkish healthcare providers, research institutes, or international accounts — cannot be characterized from the available evidence.

Short descriptiontext

Bioeksen R&D Technologies is a private Istanbul-based biotechnology firm, founded in 2014, that develops molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing services for clinical and research customers.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersIstanbul
HQ citystring
Istanbul
Markets served

Serves global market

Keyword5 values
molecular diagnostics, PCR test kits, NGS services, biotechnology research, diagnostic systems
Industry4 codes
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
NAICS code3 codes
  • Medical Laboratories621511
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code4 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Molecular Diagnostics
Social media profiles1 record
Cost components4 values
Technology or R&D, Supply Chain, Personnel, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bioeksen R&D Technologies is a biotechnology firm that develops and supplies molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing (NGS) services. The company focuses on R&D-driven molecular biology tools and services used by laboratories and clinical settings for nucleic acid-based detection and analysis.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Molecular Diagnostic Systems
CategoryMolecular Diagnostics
Description

Molecular diagnostic systems designed for nucleic acid-based detection and analysis, used by clinical and research laboratories for diagnostic workflows.

2Real-Time PCR Test Kits
CategoryDiagnostic Reagents
Description

Real-time PCR test kits for molecular biology and clinical diagnostics applications, supplied to laboratories conducting nucleic acid amplification testing.

3NGS Services
CategorySequencing Services
Description

Next-Generation Sequencing services providing sequencing-based analysis to research and clinical customers requiring genomic or transcriptomic data.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Peers8 records
TypeBroad incumbent
Description

Roche operates cobas PCR systems and a broad molecular diagnostics menu including NGS oncology panels, dwarfing Bioeksen's scale but serving overlapping clinical laboratories and hospital customers.

TypeDirect peer
Description

Qiagen is a global molecular diagnostics and sample-prep provider spanning PCR assays, NGS library prep, and instruments — the most comprehensive direct overlap with Bioeksen's combined PCR/NGS portfolio.

TypeBroad incumbent
Description

Illumina dominates NGS sequencing platforms and reagents; while Bioeksen is more likely a customer/partner than direct competitor, Illumina's installed base defines the NGS services market Bioeksen serves.

TypeDirect peer
Description

Bio-Rad is a global leader in real-time PCR instruments (CFX), diagnostic kits, and droplet digital PCR, directly competing with Bioeksen's PCR kit and instrument offerings across clinical and research customers.

TypeDirect peer
Description

Anatolia Geneworks is a Turkey-based molecular diagnostics and genetic testing company offering PCR kits, DNA/RNA extraction, and genotyping services, making it the closest domestic peer to Bioeksen in both geography and product mix.

TypeEmerging player
Description

GenMark (now part of Roche) developed molecular diagnostic panels on its ePlex platform, illustrating the multiplex molecular diagnostics niche that Bioeksen's PCR kit business targets.

TypeBroad incumbent
Description

Thermo Fisher offers Applied Biosystems qPCR instruments, Ion Torrent NGS, and diagnostic test kits, competing across both of Bioeksen's core product lines as part of a far broader life-sciences portfolio.

TypeRegional player
Description

RTA Laboratories is a Turkish molecular diagnostics and genetic testing provider, serving as a regional peer with comparable PCR- and genetic-testing offerings concentrated in the Turkish market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioeksen R&D Technologies

Molecular Diagnosticsbioeksen.com.tr

Bioeksen R&D Technologies is a private Istanbul-based biotechnology firm, founded in 2014, that develops molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing services for clinical and research customers.

What Bioeksen R&D Technologies does

Bioeksen R&D Technologies is a private, for-profit biotechnology firm headquartered in Istanbul, Turkey, founded in 2014. According to its firmographic profile, the company develops and offers molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing (NGS) services. This positions it within the clinical and research molecular diagnostics value chain, serving customers who require nucleic-acid-based pathogen detection, genetic testing, and sequencing-based analysis.

The company's product surface spans three interrelated layers: instrumentation (molecular diagnostic systems), consumables (real-time PCR test kits), and service revenue (NGS services). This combination suggests an integrated model where the firm both sells physical diagnostic products and performs sequencing work on behalf of clients, typical of small-cap molecular diagnostics boutiques that compete on assay design, turnaround time, and local-market reach. Founded in 2014 and headquartered in Istanbul, Bioeksen operates with a headcount of 11-50 employees, indicating a small, specialist team rather than a scaled commercial platform.

The input data does not disclose pricing models, customer segments, distribution channels, go-to-market strategy, or ownership details. The company's website was inaccessible at the time of capture (presenting only a loader/verification page), which prevented extraction of corporate history, investor information, certifications, or partnerships. Consequently, the business model — specifically how revenue is split between kit sales, instrument placement, and service fees, and whether customers are concentrated in Turkish healthcare providers, research institutes, or international accounts — cannot be characterized from the available evidence.

Bioeksen R&D Technologies firmographics

Firmographics
Name
Bioeksen R&D Technologies
Website
https://bioeksen.com.tr
Company type
Private
Founded year
2014
Headcount range
101–250 employees
Short description
Bioeksen R&D Technologies is a private Istanbul-based biotechnology firm, founded in 2014, that develops molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing services for clinical and research customers.
Ownership category
akta.pro rank

Bioeksen R&D Technologies industry classification

Industry
Product category
Molecular Diagnostics
NAICS
Medical Laboratories (621511), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)

Keywords

  • Molecular diagnostics
  • PCR test kits
  • NGS services
  • Biotechnology research
  • Diagnostic systems

Where Bioeksen R&D Technologies is headquartered

Location

Headquarters

HQ city
Istanbul

Markets served

Bioeksen R&D Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations

Bioeksen R&D Technologies product offering

Product offering

Core offering

Bioeksen R&D Technologies is a biotechnology firm that develops and supplies molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing (NGS) services. The company focuses on R&D-driven molecular biology tools and services used by laboratories and clinical settings for nucleic acid-based detection and analysis.

Differentiator

Problem solved

Functional benefit

Products and services

  • Molecular Diagnostic Systems Molecular diagnostic systems designed for nucleic acid-based detection and analysis, used by clinical and research laboratories for diagnostic workflows.
  • Real-Time PCR Test Kits Real-time PCR test kits for molecular biology and clinical diagnostics applications, supplied to laboratories conducting nucleic acid amplification testing.
  • NGS Services Next-Generation Sequencing services providing sequencing-based analysis to research and clinical customers requiring genomic or transcriptomic data.

Companies that use Bioeksen R&D Technologies

Customer profile

Ideal customer profiles1 record

Bioeksen R&D Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bioeksen R&D Technologies partnerships and signals

Strategic signal

Recent moves2 records

Bioeksen R&D Technologies competitors and assessment

Company assessment

Broad incumbents

  • Roche Diagnostics: Roche operates cobas PCR systems and a broad molecular diagnostics menu including NGS oncology panels, dwarfing Bioeksen's scale but serving overlapping clinical laboratories and hospital customers.
  • Illumina: Illumina dominates NGS sequencing platforms and reagents; while Bioeksen is more likely a customer/partner than direct competitor, Illumina's installed base defines the NGS services market Bioeksen serves.
  • Thermo Fisher Scientific: Thermo Fisher offers Applied Biosystems qPCR instruments, Ion Torrent NGS, and diagnostic test kits, competing across both of Bioeksen's core product lines as part of a far broader life-sciences portfolio.

Direct peers

  • Qiagen: Qiagen is a global molecular diagnostics and sample-prep provider spanning PCR assays, NGS library prep, and instruments — the most comprehensive direct overlap with Bioeksen's combined PCR/NGS portfolio.
  • Bio-Rad Laboratories: Bio-Rad is a global leader in real-time PCR instruments (CFX), diagnostic kits, and droplet digital PCR, directly competing with Bioeksen's PCR kit and instrument offerings across clinical and research customers.
  • Anatolia Geneworks: Anatolia Geneworks is a Turkey-based molecular diagnostics and genetic testing company offering PCR kits, DNA/RNA extraction, and genotyping services, making it the closest domestic peer to Bioeksen in both geography and product mix.

Emerging players

  • GenMark Diagnostics: GenMark (now part of Roche) developed molecular diagnostic panels on its ePlex platform, illustrating the multiplex molecular diagnostics niche that Bioeksen's PCR kit business targets.

Regional players

  • RTA Laboratories: RTA Laboratories is a Turkish molecular diagnostics and genetic testing provider, serving as a regional peer with comparable PCR- and genetic-testing offerings concentrated in the Turkish market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Bioeksen R&D Technologies social profiles

Digital presence

Bioeksen R&D Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioeksen R&D Technologies leadership team

Management profile

Number of profiles

Bioeksen R&D Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioeksen R&D Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioeksen R&D Technologies

What does Bioeksen R&D Technologies do?

Bioeksen R&D Technologies is a biotechnology firm that develops and supplies molecular diagnostic systems, real-time PCR test kits, and Next-Generation Sequencing (NGS) services. The company focuses on R&D-driven molecular biology tools and services used by laboratories and clinical settings for nucleic acid-based detection and analysis.

When was Bioeksen R&D Technologies founded?

Bioeksen R&D Technologies was founded in 2014. It employs 101 to 250 people.

Where is Bioeksen R&D Technologies based?

Bioeksen R&D Technologies is headquartered in Istanbul.

Who are Bioeksen R&D Technologies's main competitors?

Broad incumbents on record are Roche Diagnostics, Illumina and Thermo Fisher Scientific. Direct peers are Qiagen, Bio-Rad Laboratories and Anatolia Geneworks. GenMark Diagnostics is listed as an emerging player. RTA Laboratories is listed as a regional player.

Does Bioeksen R&D Technologies have an API?

No public API is recorded for Bioeksen R&D Technologies.

What industry is Bioeksen R&D Technologies in?

Bioeksen R&D Technologies's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales